Abraxane With Bevacizumab Biosimilar in Patients With Recurrent, Platinum-resistant Epithelial Ovarian Cancer
Clinical trial NCT04670978 · UNKNOWN
Trial details
- NCT number
- NCT04670978
- Sponsor
- Shandong University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-31
- Primary completion
- 2023-12-31
- Enrollment
- 96
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.